Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Research output: Contribution to journalJournal articleResearchpeer-review

  • Jaikumar Duraiswamy
  • Riccardo Turrini
  • Aspram Minasyan
  • David Barras
  • Isaac Crespo
  • Alizée J. Grimm
  • Julia Casado
  • Raphael Genolet
  • Fabrizio Benedetti
  • Alexandre Wicky
  • Kalliopi Ioannidou
  • Wilson Castro
  • Christopher Neal
  • Amandine Moriot
  • Stéphanie Renaud-Tissot
  • Victor Anstett
  • Noémie Fahr
  • Janos L. Tanyi
  • Monika A. Eiva
  • Connor A. Jacobson
  • Kathleen T. Montone
  • Marie Christine Wulff Westergaard
  • Lana E. Kandalaft
  • Mauro Delorenzi
  • Peter K. Sorger
  • Anniina Färkkilä
  • Olivier Michielin
  • Vincent Zoete
  • Santiago J. Carmona
  • Periklis G. Foukas
  • Daniel J. Powell
  • Sylvie Rusakiewicz
  • Marie Agnès Doucey
  • Denarda Dangaj Laniti
  • George Coukos

The mechanisms regulating exhaustion of tumor-infiltrating lymphocytes (TIL) and responsiveness to PD-1 blockade remain partly unknown. In human ovarian cancer, we show that tumor-specific CD8+ TIL accumulate in tumor islets, where they engage antigen and upregulate PD-1, which restrains their functions. Intraepithelial PD-1+CD8+ TIL can be, however, polyfunctional. PD-1+ TIL indeed exhibit a continuum of exhaustion states, with variable levels of CD28 costimulation, which is provided by antigen-presenting cells (APC) in intraepithelial tumor myeloid niches. CD28 costimulation is associated with improved effector fitness of exhausted CD8+ TIL and is required for their activation upon PD-1 blockade, which also requires tumor myeloid APC. Exhausted TIL lacking proper CD28 costimulation in situ fail to respond to PD-1 blockade, and their response may be rescued by local CTLA-4 blockade and tumor APC stimulation via CD40L.

Original languageEnglish
JournalCancer Cell
Volume39
Issue number12
Pages (from-to)1623-1642.e20
ISSN1535-6108
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 Elsevier Inc.

    Research areas

  • CD28, CD40, CTLA-4, dendritic cell, exhaustion, myeloid niche, ovarian, PD-1, TIL, tumor

ID: 302196217